Korea Market Insights

Moderna (MRNA) stock went on a roller coaster ride this week. Closing price on Tuesday, August 18th: $62.96. The next day: $174.38. In just one day. That's a +176.97% gain —the largest single-day jump in the company's history. By search cross-check, it's reportedly the biggest single-day rally for any S&P 500 stock this century. But then just the next day—Thursday, August 20th. As I'm writing this, U.S. markets are still open. The stock is hovering around $130, down roughly -25% from the previous day. The closing price isn't final yet. The intraday high was $155, the low around $129. It's not a crash. It's more accurately a pullback after the surge. Compared to the August 18th close, it's still up more than double over the two-day span. The Nasdaq wasn't shaken today, so why just Moderna? I looked at the broader U.S. market first on the 20th. At the same time, S&P 500 was -0.32%, Nasdaq -0.71%. The market was nudged down slightly...

Today (August 20), MicroStrategy's stock is jumping 7.66% and currently trading around $112.24. The company's massive Bitcoin holdings rallied right along as Bitcoin broke through $68,000 again following the U.S. Treasury's announcement to double its long-term bond buyback program. That said, the stock already climbed over 12% yesterday, so much of today's gains are really just a continuation of that momentum rather than fresh news. The company has even changed its name from MicroStrategy to just 'Strategy'—that's how far removed it's become from being a software company. It's essentially a Bitcoin holding and management company now. So if you want to understand this stock's price, you need to look at Bitcoin's price and the company's funding structure before you even glance at their earnings. Why Today's Surge — The Reason Bitcoin Broke $68,000 The catalyst came from the U.S. Treasury. They announced they'd double th...

Korean Kolmar's stock is trading around 137,800 won today, climbing back toward its 52-week high of 144,000 won. What's interesting is that Cosmex, which operates in the same cosmetics ODM sector and has larger revenue, saw its stock rise only +10% over the past year , while Korean Kolmar's stock jumped +71% in the same period. I dug into why there's such a temperature gap between companies that manufacture cosmetics on behalf of other brands. Did the whole sector rise, or is Korean Kolmar just exceptionally strong? First, I need to check whether this is just Korean Kolmar's story, or if the entire K-beauty ODM sector benefited equally. Looking at the 3-month returns alongside three other companies in the same sector, here's what I see: · Korean Kolmar +51.1% (1-year +71.0%, P/E 26.0x, Operating Margin 8.8%) · Cosmekaco Korea +82.2% (1-year +119.5% , P/E 32.2x, Operating Margin 13.0%) · Cosmex +42.3% (1-year +10.1%, P/E 24.0x, Operating Margin 8...

On August 20, 2026, the KOSPI index closed at 6,852.58, jumping 5.89% in a single day. The index had plunged 5.80% the day before, and today it nearly recovered the entire loss. But the real story here isn't the index—it's who was doing the buying and selling. Retail investors who snapped up ₩4.6 trillion worth on yesterday's crash unloaded ₩2.2 trillion today, while foreign investors, who had dumped ₩3.5 trillion yesterday, came back in to buy ₩1.7 trillion. Talk about a complete reversal in 24 hours. KOSPI seller-buyer breakdown on crash day (8/19) and rally day (8/20)—personally compiled and created Index and money flow, by the numbers The KOSPI index gapped up from 6,680, touched a high of 6,904.55 (+6.70%) during the session, then gave back some of those gains to close at 6,852.58. The rally was so large that it triggered the 24th buy-side circuit breaker of the year. Given that the sell-side breaker had been hit the day before, it was unusual to see both...

Today, Ingenia Therapeutics (Reg.S) (950260) has surged again in a major way. The current price is around 18,330 KRW , with gains up +30.00% —and climbing. Given that this stock has already experienced multiple swings in just three trading days since its KOSDAQ listing, I'm sure many of you are wondering, "What does this company even do that makes it move like this?" A Roller Coaster Four Days After Listing—Here's the Journey So Far Ingenia Therapeutics listed on KOSDAQ on August 18. The IPO price was set at 12,000 KRW, but on listing day itself, it dipped below that early in the session before staging a dramatic turnaround to close at 17,990 KRW (+49.92%) on its first day. The next day, the 19th, it posted double-digit gains during the session, maintaining its volatility, and today (the 20th) it's surging again, hovering around +30% . Being a newly listed stock with limited float, investor flows dynamics can get skewed easily—that's the natur...

Genexine's stock surged nearly 29% during today's trading session , climbing to the 3,200 won range. What was trading at 2,400 won just yesterday skyrocketed to near the daily limit in a single day. When you see a biotech company focused on gene and protein therapies jump this suddenly, you naturally wonder: "What just happened?" Did Today's Surge Hit the Whole Market, or Just Genexine? The KOSDAQ has been on a bullish run over the past month, led by biotech and growth stocks. But the index itself never swings 30% in a single day. Given that KOSDAQ typically moves around 1% daily, Genexine's move is clearly a company-specific story , not a broader market shift. Companies in the same gene therapy space—like Shinlabs, Apexigen, and Toolgen—have historically rallied as a group when one gets good news. So we need to check the supply-and-demand picture after market close to see whether today's move is a Genexine-only thing or a theme that's spre...

Good morning, August 20, 2026. Yesterday (August 19), the KOSPI dropped 398.66 points (-5.80%) in a single day, closing at 6,471.17, with a sell-side sidecar even triggered during the session. But here's the irony—the very market that caused all this, US stocks, staged a simultaneous rally that night (August 19 local time). The Dow, Nasdaq, and S&P 500 all bounced back hard when the US Treasury Department announced it would expand its long-term Treasury buyback program. The relentless rate hike pressure that had been suffocating markets finally eased. Today, we'll be watching closely to see if the Korean market can recoup yesterday's losses in full. US market map last night (S&P500 heatmap) · Green=gains/Red=losses (finviz US style) All three major US indices staged a comeback after four trading days On August 19 (local time), the New York market halted its three-day slide and rallied across the board. The Dow Jones Industrial Average closed up 119.65...

On August 20, 2026, MicroStrategy (MSTR) stock jumped 11.90% on U.S. markets and is now trading around $103.53. Just yesterday on the 19th, it had already rocketed 14.05% to $105.52, so we're looking at back-to-back double-digit rallies—a rare sight. At this point, the company is less of a software vendor and more like a publicly traded Bitcoin trust. So if you want to know why the stock jumped, you've got to watch Washington and Bitcoin prices before you even glance at earnings. Why did it pop today? The direct trigger was a crypto policy meeting at the White House on August 19. President Trump convened SEC Chair Paul Atkins, CFTC Chair Michael Sellig, and crypto industry leaders from Coinbase, Ripple, Gemini, and Robinhood. The market saw this as a signal that regulatory uncertainty is clearing , and Bloomberg noted that Bitcoin had its biggest move since March leading into the meeting. When Bitcoin rises, MicroStrategy's stock typically swings even harder....

Marvell stock (MRVL) is up 10.77% today, trading around $239.27—a double-digit pop that stands out against a quiet day in semiconductors overall. The reason is straightforward: this morning, Marvell filed that Google just received warrants to purchase—not $122 million in company stock, but a whopping $12.2 billion worth. And that's why the market is celebrating. What exactly happened? Back on July 29th, Marvell and Google signed a commercial agreement to jointly develop custom chips. Then on August 18th, Marvell filed an 8-K disclosing that it issued Google warrants to purchase up to 58.97 million shares at $206.58 per share —totaling $12.2 billion if fully exercised. The news hit like a spark: Marvell jumped double digits in premarket trading and kept the momentum rolling through the regular session. But here's the kicker—Google won't exercise all those warrants at once. In year one, only about 1.36 million shares will vest equally each quarter. The rest unlock...

On August 19, 2026, the KOSPI index closed at 6,471.17. In just one day, it fell 398.66 points (−5.80%) , and circuit breakers were even triggered mid-session. But the number that stood out most that day wasn't the index decline itself. It was that while foreign investors and institutions were selling off together, retail investors alone bought over ₩4.6 trillion worth. Let me trace why these two sides moved in completely opposite directions as the market collapsed. Why Did the Index Collapse Like That? The KOSPI started at 6,528.77, already down nearly 5%, and fell as low as 6,400.81 (−6.83%) during the session. Early on, it briefly recovered to 6,614.39, but selling pressure returned and it finally closed at 6,471.17. That day marked the 48th circuit breaker event on the KOSPI, with 25 of those being sell-side triggers. Circuit breakers are safety mechanisms that lock algorithmic trading for 5 minutes when futures prices move sharply in a short timeframe—the fact they w...

Bionia stock headed straight to the upper limit this morning. It surged to 9,190 won, up 29.99% from the previous trading day , but of all days, KOSPI plummeted over 4% right at the open and even triggered a sell-side sidecar, while KOSDAQ started down 2%. The fact that this stock alone hit the upper limit while the entire market collapsed tells us this move isn't about market sentiment—it's something that happened purely within this company itself. Two pieces of news broke this morning. First, Q2 earnings hit record highs for the quarter. Second, the company's hair loss research results were published in an international academic journal. With earnings and new drug news hitting on the same day, it looks like buying pressure flooded in all at once. What kind of company is Bionia? It started in 1992 as Korea's first biotech venture. It was the first to commercialize gene amplification technology (PCR) domestically, and now beyond its existing diagnostics ...